Abstract:Introduction: Alzheimer’s disease (AD) is a progressive and incurable neurodegenerative condition that affects millions of people worldwide. The search for effective treatments for this disease has long been a priority in healthcare. In recent years, interest in the use of cannabidiol (CBD), one of the compounds found in the Cannabis sativa plant, has grown due to its potential therapeutic properties. A literature review was conducted covering searches in electronic databases, such as PubMed, SciELO and LILACS, with the aim of gathering as much information on the selected theme. Descriptors such as “Alzheimer”, “Cannabidiol”, “Treatment” and “CBD” were used, combined with the Boolean operator AND. The selection of articles considered the date of recent publication, limited to the last 10 years, as well as research related to the same theme and articles in Portuguese or foreign language (English). Duplicate articles, those that did not fit the proposed theme, as well as theses, monographs and dissertations were excluded. It was observed that CBD has characteristics often associated with Alzheimer’s therapy, such as anti-inflammatory, neuroprotective properties and mild adverse effects. The results indicated that the use of CBD in Alzheimer’s treatment shows promising potential. CBD was found to be especially beneficial for patients with neurodegenerative diseases. In conclusion, Cannabis is a viable substance given its promising therapeutic properties in the context of neuronal health, and its approach shows positive results in terms of recovery, symptomatologic improvement, and quality of life for patients affected by Alzheimer’s. Despite limitations and the need for further studies, results to date suggest that CBD may represent a promising option for symptomatic treatment and possibly even for modifying disease progression. However, it is critical to conduct larger-scale controlled clinical trials to confirm these findings and establish clear guidelines for its clinical use. These results may provide input for the development of future research and promising therapeutic strategies for Alzheimer’s disease.

A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research

Exploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment

Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer's Disease

Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging

A combination of Δ9-tetrahydrocannabinol and cannabidiol modulates glutamate dynamics in the hippocampus of an animal model of Alzheimer's disease

Cannabidiol in the treatment and prevention of Alzheimer’s disease – a comprehensive overview of in vitro and in vivo studies

Exploring the Therapeutic Potential of Natural Compounds for Alzheimer's Disease: Mechanisms of Action and Pharmacological Properties.

Cannabinerol Prevents Endoplasmic Reticulum and Mitochondria Dysfunctions in an In Vitro Model of Alzheimer's Disease: A Network-Based Transcriptomic Analysis

CANNABIDIOL AS A NOVEL THERAPY FOR ALZHEIMER’S DISEASE

Medicinal cannabis extracts are neuroprotective against Aβ1-42-mediated toxicity in vitro

Boosting Acetylcholine Signaling by Cannabidiol in a Murine Model of Alzheimer's Disease

Cannabidiol Ameliorates Cognitive Decline in 5xfad Mouse Model of Alzheimer's Disease Through Potentiating the Function of Extrasynaptic Glycine Receptors

Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders

Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease

Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)

Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases

Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease

Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide 25–35

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer's disease through potentiating the function of extrasynaptic glycine receptors